Abstract:Natural products are structurally highly diverse and exhibit a wide array of biological activities. As a result, they serve as an important source of new drug leads. Traditionally, natural products have been discovered by bioactivity-guided fractionation. The advent of genome sequencing technology has resulted in the introduction of an alternative approach towards novel natural product scaffolds: Genome mining. Genome mining is an in-silico natural product discovery strategy in which sequenced genomes are analyzed for the potential of the associated organism to produce natural products. Seemingly universal biosynthetic principles have been deciphered for most natural product classes that are used to detect natural product biosynthetic gene clusters using pathway-encoded conserved key enzymes, domains, or motifs as bait. Several generations of highly sophisticated tools have been developed for the biosynthetic rule-based identification of natural product gene clusters. Apart from these hard-coded algorithms, multiple tools that use machine learning-based approaches have been designed to complement the existing genome mining tool set and focus on natural product gene clusters that lack genes with conserved signature sequences. In this perspective, we take a closer look at state-of-the-art genome mining tools that are based on either hard-coded rules or machine learning algorithms, with an emphasis on the confidence of their predictions and potential to identify non-canonical natural product biosynthetic gene clusters. We highlight the genome mining pipelines' current strengths and limitations by contrasting their advantages and disadvantages. Moreover, we introduce two indirect biosynthetic gene cluster identification strategies that complement current workflows. The combination of all genome mining approaches will pave the way towards a more comprehensive understanding of the full biosynthetic repertoire encoded in microbial genome sequences. Beilstein J. Org. Chem. 2022, 18, 1656–1671. doi:10.3762/bjoc.18.178

Genome Mining for Novel Natural Product Discovery

Genome Mining as New Challenge in Natural Products Discovery

Genome mining for the search and discovery of bioactive compounds: The Streptomyces paradigm

Navigating and expanding the roadmap of natural product genome mining tools

The re-emergence of natural products for drug discovery in the genomics era

Targeted Genome Mining—From Compound Discovery to Biosynthetic Pathway Elucidation

Using Natural Products for Drug Discovery: the Impact of the Genomics Era

Genome Mining Enabled by Biosynthetic Characterization Uncovers a Class of Benzoxazolinate‐Containing Natural Products in Diverse Bacteria

Genome mining as a biotechnological tool for the discovery of novel marine natural products

A mass spectrometry–guided genome mining approach for natural product peptidogenomics

High-Throughput Mining of Novel Compounds from Known Microbes: A Boost to Natural Product Screening

Targeting Bacterial Genomes for Natural Product Discovery

Genome Mining Reveals Novel Biosynthetic Gene Clusters in Entomopathogenic Bacteria

Focused Natural Product Elucidation by Prioritizing High-Throughput Metabolomic Studies with Machine Learning

Genome mining and prospects for antibiotic discovery

Genome mining strategies for ribosomally synthesised and post-translationally modified peptides

Discovering new bioactive molecules from microbial sources

Prospecting for natural products by genome mining and microcrystal electron diffraction

Automated, Self-Resistance Gene-Guided, and High-Throughput Genome Mining of Bioactive Natural Products from Streptomyces

Recent advances in genome mining and synthetic biology for discovery and biosynthesis of natural products

Recent advances in natural product discovery.